UGE:ARCA-ProShares Ultra Consumer Goods (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 18.4009

Change

0.00 (0.00)%

Market Cap

USD 9.06M

Volume

6.83K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Consumer GoodsSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the stock performance of U.S. companies in the consumer goods sector of the U.S. equity market. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Consumer Goods TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.65%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 7.96B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 7.84B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.60B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 4.27B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.43B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.61B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.91B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.82B

ETFs Containing UGE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.91% 58% F 74% C
Dividend Return 1.07% 53% F 17% F
Total Return 17.98% 58% F 71% C-
Trailing 12 Months  
Capital Gain 16.91% 58% F 74% C
Dividend Return 1.07% 53% F 17% F
Total Return 17.98% 58% F 71% C-
Trailing 5 Years  
Capital Gain 38.72% 65% D 70% C-
Dividend Return 4.64% 77% C+ 12% F
Total Return 43.36% 65% D 64% D
Average Annual (5 Year Horizon)  
Capital Gain -4.36% 6% D- 14% F
Dividend Return -3.78% 4% F 10% F
Total Return 0.57% 42% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 62.46% 63% D 15% F
Risk Adjusted Return -6.06% 7% C- 17% F
Market Capitalization 9.06M 8% B- 7% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.